Name (Synonyms) | Correlation | |
---|---|---|
drug1933 | Proton Therapy Wiki | 1.00 |
drug905 | F-FMISO PET/CT Scan Wiki | 1.00 |
drug2951 | placebo (hartmann plus albumine) Wiki | 1.00 |
drug654 | Convalescent Plasma of patients with COVID-19 Wiki | 1.00 |
drug45 | 5Fluorouracil Wiki | 1.00 |
drug34 | 30 Gy over 3 weeks Wiki | 1.00 |
drug522 | Carboplatin Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D002294 | Carcinoma, Squamous Cell NIH | 1.00 |
D002277 | Carcinoma NIH | 0.45 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002860 | Squamous cell carcinoma HPO | 1.00 |
HP:0030731 | Carcinoma HPO | 0.45 |
There is one clinical trial.
The purpose of this study is to demonstrate that participants with HPV positive and hypoxia negative T1-2, N1-2c (AJCC, 7th ed.) oropharyngeal squamous cell carcinoma receiving a major de-escalated radiation therapy with 2 cycles of standard chemotherapy is not inferior to comparable subjects treated with the current standard chemoradiation. Given the restrictions of surgery during the COVID19 pandemic, we will start enrolling patients on Cohort B where surgery is not required. Once the COVI19 pandemic is over, we will resume and complete enrollment on Cohort A where surgery is required, prior to continuing enrolling patients on Cohort B. During the COVID-19 pandemic, the research MRIs are optional.